Latest Inflammatory myopathy Stories

SAN DIEGO and WASHINGTON, Nov. 8, 2012 /PRNewswire/ -- aTyr Pharma, an innovator in immune-modulating protein therapeutics, announced today their presentation at the 2012 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Meeting, which is being held November 9-14 in Washington, D.C. The presentation provides an in-depth molecular characterization of Jo-1 antibodies, which occur as part of a rare, human autoimmune response to...

Researchers in Montreal say inflammatory diseases -- polymyositis and dermatomyositis -- are linked to increased cardiovascular risk. The study, published in The Journal of Rheumatology, also find the immunosuppressive therapies currently used to treat the two inflammatory diseases looked at in the study --polymyositis and dermatomyositis -- may have a preventive effect against heart attacks. This is an extremely interesting finding for patients who are suffering from polymyositis and...